To support the work of the Joint Expert Meeting on Microbiological Risk Assessment (JEMRA), FAO/WHO are seeking experts and data on the use of omics-based technologies for pathogen detection, outbreak root cause analyses, surveillance, food process monitoring programs, and microbiological risk assessments.
The Canadian Food Inspection Agency (CFIA) has published the latest National Microbiological Monitoring Program Annual Report for 2023–2024, which assesses domestic and imported food samples and industry environmental samples.
Following the withdrawal of the previously proposed strategy for reducing Salmonella in poultry, USDA-FSIS will host a public meeting on January 14 to advance work on a new approach, facilitating a discussion on “practical strategies” that “reflect both public health goals and industry realities.”
Mettler-Toledo Product Inspection Group has introduced its new X3 Series of bulk flow X-ray inspection systems for physical contamination detection. Typical applications include fruits and vegetables, nuts, pulses, confectionery, and cereals.
The nationwide infant botulism outbreak associated with ByHeart infant formula has grown to 39 cases in 18 states. All 39 infants were hospitalized; no deaths have been reported.
The sampling and testing project will support the National Antimicrobial Resistance Monitoring System (NARMS) by identifying trends and emerging risks from drug-resistant foodborne bacteria. Findings will be used to create a model that can help predict and address antimicrobial resistance (AMR) mitigation strategies.
The French agency ANSES published the results of a two-year, national sampling and testing assignment for “forever chemicals” in drinking water, which was conducted to inform future monitoring strategies. Although most analyzed samples fell below regulatory limits for PFAS, TFA was found in 92 percent of samples.
As of December 2, laboratory-confirmed cases in the ongoing Salmonella outbreak linked to pistachios has reached 155, and CFIA now requires importers and manufacturers of Iranian pistachios to hold and test their products for Salmonella before they can be sold.
Posted to the Unified Agenda in September, FDA’s developing proposed rule to tighten Generally Recognized as Safe (GRAS) oversight has been sent to the White House for review—the final step before publication.
Although the estimated cost per disease incident ranged from $341 USD in Africa to $2,194 in Europe, the total economic burden of invasive non-typhoidal Salmonella was highest in Africa—especially sub-Saharan Africa—due to its prevalence and overall impact to public health in the region.